K
KoBioLabs
Biotech & Life Sciences · Seoul, South Korea · Founded 2014
Engaged in patents and studies in various fields including microbiome analysis, probiotics, and microbiome treatment technology MoreLess
KoBioLabs operates in the biotechnology sector, focusing on the development of microbiome-based products that promote beneficial interactions between the human body and the environment. The company serves a diverse range of clients, including healthcare providers, environmental organizations, and consumers seeking health and wellness solutions. KoBioLabs leverages its expertise in microbiomes to create products that improve health outcomes and environmental sustainability. The business model revolves around research and development, product sales, and strategic partnerships. Revenue is generated through the sale of proprietary microbiome products and solutions, as well as through collaborations and licensing agreements. KoBioLabs is committed to providing a supportive environment for its employees, fostering creativity and passion, and ensuring high returns on investment for its stakeholders.
Keywords: biotechnology, microbiome, health, environment, sustainability, R&D, partnerships, innovation, wellness, proprietary products.
Talent graph
KoBioLabs's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on KoBioLabs's cap table
Sourced from Dealroom's funding and investor records.

Global footprint
Where KoBioLabs has talent and traffic
team presence
Market sentiment
What the market is saying about KoBioLabs
An AI-synthesized read of the highest-engagement posts about KoBioLabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See KoBioLabs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.